SOPHIA HOLDINGS CO.,LTD.
6942・Standard Market・Information & Communication
Business
Sophia Holdings Co., Ltd. is a TSE Standard-listed pure holding company overseeing 8 consolidated subsidiaries. Centered on its Dispensing Pharmacy and Related Business (operating 60 stores), which accounts for approximately 84% of revenue, the group consists of three segments: this core business, the Internet-Related Business (IT engineer dispatch and system development), and the Telecommunications Business (centered on MVNO). Consolidated revenue for FY2026 (ending March 2026) was ¥8,329 million. The company entered the dispensing pharmacy business through a business alliance with its parent company, E-BOND Holdings, and positions group synergies from the fusion of ICT and healthcare as a pillar of its medium- to long-term strategy.
Business Model
The majority of revenue consists of medical service fee and drug price income from prescription dispensing and pharmaceutical sales at dispensing pharmacies. In the Internet-Related Business, the company earns recurring service revenue through System Engineering Dispatch Services (SES Business) and contracted system development. The Telecommunications Business generates revenue from reselling MVNO lines and providing corporate solutions. Expanding the store and engineer base through M&A, along with cost reductions and service enhancement through group-wide synergies, serve as means of improving profitability.
Company Strengths
Through repeated M&A and business acquisitions, the company operated 60 dispensing pharmacy stores as of the end of FY2026 (ending March 2026). Revenue reached ¥6,972 million (up 0.4% year on year) and segment profit reached ¥363 million (up 75.7% year on year), forming a stable foundation for group revenue. The number of patients visiting continues to increase, and the community-based store network underpins revenue.
The company holds three segments—Dispensing Pharmacy and Related Business, IT engineer dispatch and system development, and MVNO Services—thereby diversifying single-industry risk. In FY2026 (ending March 2026), the Internet-Related Business achieved a segment profit margin of 5.7%, and the Telecommunications Business turned profitable (segment profit of ¥27 million), with each business functioning as an independent revenue source.
Since 2018, the company has acquired and integrated multiple pharmacy chains in the Dispensing Pharmacy and Related Business, building a 60-store network. In October 2025, it made Sophia Security Co., Ltd. (formerly Security Agent Co., Ltd.) a subsidiary, expanding the scope of the Internet-Related Business. The company's ability to execute business expansion through M&A can be confirmed in the corporate history section of its securities report.
ENVALITH's Perspective
Performance Trend
Revenue peaked at ¥11,783 million in FY2022 (ending March 2022) and has since contracted for five consecutive fiscal years, reaching ¥8,329 million in FY2026 (ending March 2026), down 0.4% year on year. Operating profit had recovered to ¥345 million in FY2025 (ending March 2025), but fell into an operating loss of ¥60 million in FY2026 (ending March 2026). The Dispensing Pharmacy segment achieved a significant improvement in profit (¥363 million, up 75.7% year on year) through increased patient visits and reduced SG&A expenses, even amid headwinds from drug price revisions, but a structural issue has emerged whereby the holding company's group-wide adjustment costs of ¥503 million exceed the total segment profit of ¥457 million. External factors—the ongoing impact of drug price and dispensing fee revisions, as well as intensifying competition in the MVNO market—continue to weigh on performance. The company forecasts a recovery to revenue of ¥8,928 million and operating profit of ¥159 million in FY2027 (ending March 2027).
Growth Strategy
Expansion of dispensing pharmacy stores and profitability improvement, combined with ICT × healthcare integration to create group synergies
Continuing to expand the store network through business acquisitions (¥144 million spent in FY2026 (ending March 2026)). Building on the 60-store base as of the end of FY2026 (ending March 2026), the company will pursue new store openings and acquisitions while weighing capital efficiency and earnings contribution, aiming to improve profitability through scale merits.
Continuing to review operations across 60 stores and rationalize unprofitable stores to compress selling, general and administrative expenses. In FY2026 (ending March 2026), the Dispensing Pharmacy and Related Business segment profit improved significantly to ¥363 million (up 75.7% year on year), reflecting the effects of these measures.
Expanding the scope of the ICT business through active M&A, including making Security Agent a subsidiary. Also focusing on recruiting and developing engineers skilled in generative AI, cloud development, and infrastructure construction, aiming to expand revenue by capturing DX demand.
In the Telecommunications Business, revenue reached ¥228 million (up 49.4% year on year) with a segment profit of ¥27 million in FY2026 (ending March 2026), turning profitable. The company will continue to drive revenue and profit growth in the MVNO business by strengthening sales of its in-house developed Customer Order Systems and launching new businesses.
In FY2026 (ending March 2026), company-wide adjustment (expenses) of ¥503 million exceeded the total segment profit of ¥457 million, becoming the main cause of the operating loss. Achieving the forecast operating profit of ¥159 million in FY2027 (ending March 2026) requires substantial reduction of company-wide expenses, making efficiency improvements in group management costs an urgent priority.
Last updated: July 19, 2026

